Position in AZN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$285,188
-$3,542 QoQ
Shares Held
1,504
+2.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,064
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hoxton Planning & Management, LLC holds $4,792,204 across 8 Drug Manufacturers - General names. AZN ranks #8 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,255 | $1,505,284 | |
| 2 | JNJ |
Johnson & Johnson
|
2,875 | $730,163 | |
| 3 | PFE |
Pfizer Inc
|
26,907 | $647,920 | |
| 4 | ABBV |
AbbVie Inc.
|
2,119 | $533,225 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,039 | $383,947 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,925 | $375,862 | |
| 7 | AMGN |
Amgen Inc
|
913 | $330,615 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,504 | $285,188 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,188 | 1,504 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $288,730 | 1,464 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||